Streetbeat News

Marketing

ENVB

Enveric Biosciences has announced that a research article detailing the development of their lead therapeutic candidate, EB-373, a novel psilocin prodrug, will be featured on the cover of the Journal of Medicinal Chemistry. This publication could signify a significant milestone for the company's research and development efforts in the field of psychedelic-inspired medicines.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:07 pm

AMZN

FDX

UPS

According to the Wall Street Journal, Amazon has surpassed both UPS and FedEx in U.S. parcel volumes, indicating a significant shift in the logistics and delivery landscape.

Portfolio Pulse from Charles Gross

November 27, 2023 | 12:00 pm

TSLA

A video shared by a user named Charge Go shows a Tesla car outperforming Jeeps in dune climbing, highlighting the vehicle's off-road capabilities. The video's origin is unknown. Tesla enthusiasts are awaiting the Cybertruck, which promises high performance on desert terrain. Tesla's CEO Elon Musk has teased the Cybertruck's abilities, and the first deliveries are scheduled for Nov. 30 at Gigafactory Texas. The Cybertruck is expected to have a 0-60 mph acceleration in under 3 seconds and up to 500 miles of range, with more details pending.

Portfolio Pulse from Anan Ashraf

November 27, 2023 | 11:10 am

AMZN

COST

ITRN

TGT

ZS

Investors are watching Zscaler, Amazon, Ituran Location and Control, Costco, and Target as U.S. stock futures trade lower. Zscaler is expected to report earnings before the bell, while Amazon and Costco are in focus for Cyber Monday deals. Ituran is also set to release earnings, and Target is offering deals on various brands. All mentioned stocks saw gains on Friday.

Portfolio Pulse from Lisa Levin

November 27, 2023 | 10:25 am

NVO

Novo Nordisk is currently in discussions with healthcare systems regarding flexible pricing models for its Wegovy weight loss drug, as reported by the Financial Times on Sunday.

Portfolio Pulse from Charles Gross

November 27, 2023 | 10:15 am

TSLA

The weekend featured a mix of political controversy and technological developments. Mary Trump criticized Donald Trump, while Marjorie Taylor Greene supported Jan. 6 insurrectionists. Elon Musk teased a new Starship design for SpaceX and excitement grew for Tesla's (NASDAQ:TSLA) upcoming Cybertruck launch. Wall Street experienced a week of gains with no new rate hikes indicated by the Federal Reserve.

Portfolio Pulse from Benzinga Neuro

November 27, 2023 | 9:45 am

MSFT

Grok AI chatbot, launched by Elon Musk, suggests that Musk should focus on colonizing Mars, aligning with his ambitions through SpaceX. Musk responded positively to Grok's comment. Musk has criticized Microsoft-backed OpenAI's ChatGPT for being 'censored' and 'woke', while praising Grok for being free of these constraints. He also mentioned that Grok's computational power will double every three months. Musk continues to advocate for making humanity a space-faring civilization, with Mars as a target due to its similarity to Earth and SpaceX's Starship rocket being a step towards this goal.

Portfolio Pulse from Rounak Jain

November 27, 2023 | 8:08 am

IQ

iQIYI has partnered with GSC Movies in Malaysia and Clover Films in Singapore to release Chinese films in these markets. This collaboration aims to expand the distribution and viewership of Chinese cinema in Southeast Asia.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 7:50 am

TSLA

Tesla Inc (NASDAQ:TSLA) is set to hold the delivery event for its all-electric Cybertruck at 1 p.m. CT on Thursday at the Gigafactory in Texas. The event time was clarified by Tesla's VP of Investor Relations, Martin Viecha, on his personal X account. Invites have been sent to selected retail investors, and a live stream will be available. The Cybertruck has garnered significant interest, with showrooms across the U.S. drawing crowds. Details on configuration and pricing remain undisclosed, and while Elon Musk has hinted at a future target of 250,000 Cybertruck deliveries per year, he suggests this may not be achieved until around 2025. Reservations for the Cybertruck have surpassed two million.

Portfolio Pulse from Anan Ashraf

November 27, 2023 | 6:55 am

IPHA

Innate Pharma announced a virtual KOL event to discuss lacutamab, an anti-KIR3DL2 antibody for T-cell lymphoma. Positive results from the TELLOMAK Phase 2 Trial in Sézary syndrome patients will be presented at the ASH Annual Meeting. The event is scheduled for December 12, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 6:25 am